Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial.

BACKGROUND Evidence is weak for the ability of long-term non-invasive positive pressure ventilation (NPPV) to improve survival in patients with stable hypercapnic chronic obstructive pulmonary disease (COPD). Previous prospective studies did not target a reduction in hypercapnia when adjusting ventilator settings. This study investigated the effect of long-term NPPV, targeted to markedly reduce hypercapnia, on survival in patients with advanced, stable hypercapnic COPD. METHODS This investigator-initiated, prospective, multicentre, randomised, controlled clinical trial enrolled patients with stable GOLD stage IV COPD and a partial carbon dioxide pressure (PaCO2) of 7 kPa (51.9 mm Hg) or higher and pH higher than 7.35. NPPV was targeted to reduce baseline PaCO2 by at least 20% or to achieve PaCO2 values lower than 6.5 kPa (48.1 mm Hg). Patients were randomly assigned (in a 1:1 ratio) via a computer-generated randomisation sequence with a block size of four, to continue optimised standard treatment (control group) or to receive additional NPPV for at least 12 months (intervention group). The primary outcome was 1-year all-cause mortality. Analysis was by intention to treat. The intervention was unblinded, but outcome assessment was blinded to treatment assignment. This study is registered with ClinicalTrials.gov, number NCT00710541. FINDINGS Patients were recruited from 36 respiratory units in Germany and Austria, starting on Oct 29, 2004, and terminated with a record of the vital status on July 31, 2011. 195 patients were randomly assigned to the NPPV group (n=102) or to the control group (n=93). All patients from the control group and the NPPV group were included in the primary analysis. 1-year mortality was 12% (12 of 102 patients) in the intervention group and 33% (31 of 93 patients) in the control group; hazard ratio 0.24 (95% CI 0.11-0.49; p=0.0004). 14 (14%) patients reported facial skin rash, which could be managed by changing the type of the mask. No other intervention-related adverse events were reported. INTERPRETATION The addition of long-term NPPV to standard treatment improves survival of patients with hypercapnic, stable COPD when NPPV is targeted to greatly reduce hypercapnia. FUNDING German Lung Foundation; ResMed, Germany; Tyco Healthcare, Germany; and Weinmann, Germany.

[1]  T. Hedner,et al.  Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point. , 1992, Blood pressure.

[2]  H. Sitter,et al.  Non-Invasive and Invasive Mechanical Ventilation for Treatment of Chronic Respiratory Failure , 2010 .

[3]  Konrad Schultz,et al.  Leitlinie der Deutschen Atemwegsliga und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD) , 2007 .

[4]  A. Grassino,et al.  Inspiratory muscle dysfunction and chronic hypercapnia in chronic obstructive pulmonary disease. , 1991, The American review of respiratory disease.

[5]  R. Mcevoy,et al.  Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial , 2009, Thorax.

[6]  K. Schultz,et al.  [Guidelines for the diagnosis and therapy of COPD issued by Deutsche Atemwegsliga and Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin]. , 2007, Pneumologie.

[7]  P. Jones,et al.  Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. , 1995, American journal of respiratory and critical care medicine.

[8]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[9]  D. Simonson,et al.  Assessment of quality-of-life outcomes. , 1996, The New England journal of medicine.

[10]  D A Redelmeier,et al.  Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. , 1997, American journal of respiratory and critical care medicine.

[11]  M. Elliott,et al.  Domiciliary non-invasive ventilation for recurrent acidotic exacerbations of COPD: an economic analysis , 2003, Thorax.

[12]  Liam Ck.  A 4-year trial of tiotropium in chronic obstructive pulmonary disease. , 2008 .

[13]  L. Pisani,et al.  Physiological changes during low- and high-intensity noninvasive ventilation , 2011, European Respiratory Journal.

[14]  J. Roca,et al.  Pathophysiology of muscle dysfunction in COPD. , 2013, Journal of applied physiology.

[15]  J. Virchow,et al.  Outcome of patients with stable COPD receiving controlled noninvasive positive pressure ventilation aimed at a maximal reduction of Pa(CO2). , 2005, Chest.

[16]  W. Windisch.  Impact of home mechanical ventilation on health-related quality of life , 2008, European Respiratory Journal.

[17]  G. Viegi,et al.  Standardisation of the measurement of lung volumes , 2005, European Respiratory Journal.

[18]  F. Petermann,et al.  The Severe Respiratory Insufficiency (SRI) Questionnaire: a specific measure of health-related quality of life in patients receiving home mechanical ventilation. , 2003, Journal of clinical epidemiology.

[19]  T. Welte,et al.  Multizentrische Studie: „Nicht-invasive Beatmung bei Patienten mit schwerer chronisch obstruktiver Bronchitis und Emphysem (COPD)” , 2004 .

[20]  P. Jones,et al.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. , 1992, The American review of respiratory disease.

[21]  J. Virchow,et al.  Outcome of patients with stable COPD receiving controlled noninvasive positive pressure ventilation aimed at a maximal reduction of Pa(CO2): Chest 2005;128:657–62 , 2006 .

[22]  H. Sitter,et al.  Non-Invasive and Invasive Mechanical Ventilation for Treatment of Chronic Respiratory Failure S 2-Guidelines Published by The German Medical Association of Pneumology and Ventilatory Support , 2010 .

[23]  K. Kostikas,et al.  One-year non-invasive ventilation in chronic hypercapnic COPD: effect on quality of life. , 2008, Respiratory medicine.

[24]  T. Welte,et al.  [Multicenter study on "non-invasive ventilation in patients with severe chronic obstructive pulmonary disease and emphysema(COPD)"]. , 2004, Pneumologie.

[25]  ATS statement: guidelines for the six-minute walk test. , 2002, American journal of respiratory and critical care medicine.

[26]  P. Jones.  Interpreting thresholds for a clinically significant change in health status in asthma and COPD , 2002, European Respiratory Journal.

[27]  P. Jones,et al.  The St George's Respiratory Questionnaire. , 1991, Respiratory medicine.

[28]  P. Foucher,et al.  Relative survival analysis of 252 patients with COPD receiving long-term oxygen therapy. , 1998, Chest.

[29]  D. Mahler,et al.  Evaluation of the Short-Form 36-Item Questionnaire to Measure Health-Related Quality of Life in Patients With COPD , 1995 .

[30]  A. Corrado,et al.  The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients , 2002, European Respiratory Journal.

[31]  H. Sitter,et al.  Leitlinien zur Langzeit-Sauerstofftherapie , 2008, Pneumologie.

[32]  O. Burghuber,et al.  Long-term non-invasive ventilation in COPD after acute-on-chronic respiratory failure. , 2011, Respiratory medicine.

[33]  C. Schmoor,et al.  High-intensity versus low-intensity non-invasive ventilation in patients with stable hypercapnic COPD: a randomised crossover trial , 2010, Thorax.

[34]  M. Winterholler,et al.  Empfehlung zur Heim- und Langzeitbeatmung , 2006, Medizinische Klinik.

[35]  P. Wild,et al.  Weight gain in cachectic COPD patients receiving noninvasive positive-pressure ventilation. , 2006, Respiratory care.

[36]  Christine Jenkins,et al.  Health status in the TORCH study of COPD: treatment efficacy and other determinants of change , 2011, Respiratory research.

[37]  B. Celli,et al.  Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD. , 2000, Chest.

[38]  N. Anthonisen,et al.  Prognosis in chronic obstructive pulmonary disease. , 1990, The American review of respiratory disease.